Patients' quality of life and side effect perceptions in monarchE, a study of abemaciclib plus endocrine therapy in adjuvant treatment of HR+, HER2-, node-positive, high-risk, early breast cancer. (April 2021) - Tolaney, S.; Blancas, I.; Im, Y.-H.; Rastogi, P.; Brown, J.; Shahir, A.; Zimmermann, A.; Boyle, F.